AARP Fleshing Out Medicare Rx Principles Heading Into Summer Hearings
AARP is working with an actuarial firm to flesh out its Medicare Rx principles heading into the summer push for a drug benefit bill.
You may also be interested in...
AARP is prepared to mobilize its membership to block any Medicare reform legislation that is rushed through Congress without adequate consideration for its impact on beneficiaries, according to testimony given to the Senate Special Committee on Aging Feb. 8 by AARP board member Beatrice Braun, MD.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials